by Steve Adams | Oct 15, 2023
Greater Boston’s 16 million-square-foot lab construction pipeline used to represent an exclamation point for the region’s life science industry. Today, it’s one of the biggest question marks in the local commercial real estate market.
by Scott Van Voorhis | Oct 15, 2023
Yes, unbuilt suburban lab projects are unraveling and rents are sinking, but the life science industry is built on real demand and requires in-person work. Life science real estate isn’t going anywhere in Boston.
by Steve Adams | Oct 11, 2023
As developers rethink plans for additional life science projects, Bulfinch Cos. will swap out a planned lab conversion on hold at the Natick Mall in favor of a pickleball complex.
by Scott Van Voorhis | Jul 9, 2023
When it comes to real estate projects, no news is not good news. Rather, it’s an almost universal sign of bad news.
by Steve Adams | Mar 16, 2023
Bulfinch Cos. will add another biotech tenant to a Needham property that it’s updating with additional lab space this year.
by James Sanna | Aug 15, 2022
Four new multifamily projects advanced at the Boston Planning & Development Agency board of directors’ August meeting Thursday evening.
by Steve Adams | Feb 24, 2022
A commercial-and-multifamily development is proposed at a Mission Hill property acquired by Bulfinch Cos. in May 2021.
by Steve Adams | Dec 20, 2021
Boston-based developer Bulfinch Cos. is the new owner of the Natick Mall’s Neiman Marcus anchor space with plans to reposition the property.
by Steve Adams | Nov 3, 2020
Healthpeak Properties is bolstering its position as a major player in Greater Boston life science real estate with a $664 million acquisition that brings its local portfolio up to 2.4 million square feet.
by Banker & Tradesman | Oct 7, 2020
Boston-based Bulfinch Cos. plans to convert a retail property near Harvard Square to office, biotech or medical space following a recent $5 million acquisition.
by Steve Adams | Oct 7, 2019
Harvard University has received proposals from nine teams of developers to lead the first phase of its planned 36-acre Enterprise Research Campus in Allston.
by James Sanna | Oct 6, 2019
With the risk of catastrophic floods in Greater Boston increasing thanks to climate change, some area developers have already begun to respond. But new regulations mean far more projects will have to take the threat into account.
by Jay Fitzgerald | Sep 29, 2019
With recent major deals and more on the way, West Cambridge’s Alewife neighborhood has emerged as a 1.1 million-square-foot life science cluster that any other city in the nation would love to claim as its own.
by Steve Adams | May 17, 2019
Massachusetts Institute of Technology is selling a partial ownership of its 1 Portland St. and 610 and 700 Main St. office and lab buildings to Boston-based Bulfinch Cos. and Harrison Street Capital in a deal valued at $1.1 billion, or $1,626 per square foot.
by Banker & Tradesman | Mar 21, 2018
Following a long-term entire building lease by Harvard University’s technology services department, Bulfinch Cos. has obtained $30 million refinancing for 784 Memorial Drive in Cambridge.
by Steve Adams | Jun 13, 2017
Dana-Farber Cancer Institute has leased 140,000 square feet at Bulfinch Cos.’ Life Time Center in Chestnut Hill, bringing the former Atrium Mall property up to 95-percent occupancy.
by Steve Adams | Apr 11, 2017
LEED certification put energy efficiency on the radar of office tenants making lease decisions, and WELL building standards are starting to measure how workspaces can affect the health and fitness of employees.
by Banker & Tradesman | Nov 1, 2016
Needham-based Bulfinch Cos. has sold 199 Wells Ave. in Newton to AG-JCM Wells Avenue Property Owner LLC, a partnership of Angelo, Gordon & Co. of New York and Quincy-based Jumbo Capital Management, for $7 million.
by Banker & Tradesman | Sep 14, 2015
Boston-based NorthBridge CRE Advisors has acquired 20...